Skip to content

Comparative observation on adverse events of second- and third-generation iodized non-ionic contrast agents in neurological interventional surgery

Comparative observation on adverse events of second- and third-generation iodized non-ionic contrast agents in neurological interventional surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024679
Enrollment
Unknown
Registered
2019-07-20
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease

Interventions

1:Iodofol
2:Iodoxanol

Sponsors

Rong Yin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Men or women aged > 18 years; 2. Intracranial vascular disease( a. Acute ischemic stroke; b. Stroke or TIA due to intracranial and cervical aortic stenosis; c. Intracranial aneurysm; d. Intracranial arteriovenous malformation; e. Dural Arteriovenous fistula; f. intracranial venous thrombosis; g. idiopathic intracranial hypertension); 3. Head and face blood-rich tumor; intracranial space-occupying lesion; 4. Review of head and face and intracranial vascular diseases after treatment; 5. The patient or family member agrees to undergo an interventional examination or treatment; the patient or family member agrees to enroll and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Local infection at the puncture site; 3. Late cerebral palsy; 4. There is a tendency to severe bleeding, clotting factor deficiency, INR > 1.7 or platelet count =third grade, NYHA grade>=third grade.

Design outcomes

Primary

MeasureTime frame
physiological responses;allergic reactions;renal function;

Countries

China

Contacts

Public ContactRong Yin

Neurology Department of the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army

yin_rong_@163.com+86 13919930466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026